Brentuximab Vedotin
Nature Reviews Drug Discovery（2012）SCI 1区
摘要
ntibody–drug conjugate specific for CD30 approved by the US Food and Drug Administration for the treatment of two types of lymphoma.
更多查看译文
关键词
Antibody therapy,Cancer,Pharmacology,Biomedicine,general,Pharmacology/Toxicology,Biotechnology,Medicinal Chemistry,Molecular Medicine,Cancer Research
原文链接
分享
引用
